Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1976 Jan;73(1):248–251. doi: 10.1073/pnas.73.1.248

Does somatostatin inhibition of insulin secretion involve two mechanisms of action?

D L Curry, L L Bennett
PMCID: PMC335878  PMID: 1108017

Abstract

Somatostatin, the hypothalamic growth hormone release inhibitory factor (GHRIF), directly inhibits both the first and second phases of insulin secretion. The sensitivities of these two phases of insulin secretion to somatostatin differ remarkably. The first phase of secretion is approximately 25 to 50 times more sensitive to somatostatin inhibition than is the second phase. In addition, somatostatin inhibition of insulin secretion during the second phase is "reversed" by supplemental calcium, whereas the somatostatin effect on the first phase is unaffected by additional calcium. These findings suggest that the cellular events which produce the two phases of insulin secretion are separate processes, and that somatostatin has a dual mechanism of action in inhibiting insulin secretion.

Full text

PDF
250

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberti K. G., Christensen N. J., Christensen S. E., Hansen A. P., Iversen J., Lundbaek K., Seyer-Hansen K., Orskov H. Inhibition of insulin secretion by somatostatin. Lancet. 1973 Dec 8;2(7841):1299–1301. doi: 10.1016/s0140-6736(73)92873-0. [DOI] [PubMed] [Google Scholar]
  2. Curry D. L., Bennett L. L., Grodsky G. M. Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology. 1968 Sep;83(3):572–584. doi: 10.1210/endo-83-3-572. [DOI] [PubMed] [Google Scholar]
  3. Curry D. L., Bennett L. L., Grodsky G. M. Requirement for calcium ion in insulin secretion by the perfused rat pancreas. Am J Physiol. 1968 Jan;214(1):174–178. doi: 10.1152/ajplegacy.1968.214.1.174. [DOI] [PubMed] [Google Scholar]
  4. Curry D. L., Bennett L. L., Li C. H. Direct inhibition of insulin secretion by synthetic somatostatin. Biochem Biophys Res Commun. 1974 Jun 4;58(3):885–889. doi: 10.1016/s0006-291x(74)80499-7. [DOI] [PubMed] [Google Scholar]
  5. Curry D. L., Bennett L. L. Reversal of somatostatin inhibition of insulin secretion by calcium. Biochem Biophys Res Commun. 1974 Oct 8;60(3):1015–1019. doi: 10.1016/0006-291x(74)90414-8. [DOI] [PubMed] [Google Scholar]
  6. Curry D. L. Is there a common beta cell insulin compartment stimulated by glucose and tolbutamide? Am J Physiol. 1971 Feb;220(2):319–323. doi: 10.1152/ajplegacy.1971.220.2.319. [DOI] [PubMed] [Google Scholar]
  7. Douglas W. W., Poisner A. M. The influence of calcium on the secretory response of the submaxillary gland to acetylcholine or to noradrenaline. J Physiol. 1963 Mar;165(3):528–541. doi: 10.1113/jphysiol.1963.sp007076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GRODSKY G. M., FORSHAM P. H. An immunochemical assay of total extractable insulin in man. J Clin Invest. 1960 Jul;39:1070–1079. doi: 10.1172/JCI104122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gerich J. E., Lovinger R., Grodsky G. M. Inhibition by somatostatin of glucagon and insulin release from the perfused rat pancreas in response to arginine, isoproterenol and theophylline: evidence for a preferential effect on glucagon secretion. Endocrinology. 1975 Mar;96(3):749–754. doi: 10.1210/endo-96-3-749. [DOI] [PubMed] [Google Scholar]
  10. Yamashiro D., Li C. H. Synthesis of a peptide with full somatostatin activity. Biochem Biophys Res Commun. 1973 Oct 1;54(3):882–888. doi: 10.1016/0006-291x(73)90776-6. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES